- cafead Jul 06, 2022 at 12:02: AM
via GSK’s consumer healthcare spinoff will launch on the London stock market on July 18 with a new name, a new CEO and around 10.3 billion pounds of debt.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
GSK's consumer health spinoff Haleon will launch with 'significant' debt...
- Thread starter cafead
- Start date
<
Similar threads